Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Autologous Natural Killer Cell Activity in Primary Cancer Cell Cultures

NCT05869994 is registered in ClinicalTrials.gov with Sarcoma Oncology Research Center, LLC as lead sponsor.

NCT NCT05869994
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05869994 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Autologous Natural Killer Cell Activity in Primary Cancer Cell Cultures
Lead sponsor
Sarcoma Oncology Research Center, LLC
Phase
Observational
Overall status
Withdrawn
Start date
January 27, 2023
Completion date
July 1, 2024
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoma